К содержанию
CiteXCiteX — научный поиск с источниками
РецензированоEN2025

POLYCYSTIC OVARY SYNDROME AND METABOLIC SYNDROME: CLINICAL FEATURES AND MANAGEMENT STRATEGIES

Durdona Bozorova · Madina Muminova · Nilufar Toshpo'latova

Современная наука и исследования · 221-226 · 2025

Аннотация

Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders in reproductive-age women, affecting approximately 10–15% globally. It is often associated with Metabolic Syndrome (MetS), a cluster of metabolic disturbances including insulin resistance, central obesity, dyslipidemia, and hypertension. The coexistence of these two syndromes significantly increases the risk of cardiovascular disease, type 2 diabetes, and infertility.

Доказательный фрагмент

«Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders in reproductive-age women, affecting approximately 10–15% globally.»

Образец извлечения

Демо-превью

Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders in reproductive-age women, affecting approximately 10–15% globally. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Просмотров
0
Тип
Журнал
Страна
Узбекистан
Ключевые слова
Polycystic Ovary Syndrome (PCOS) affects approximately 10–15% of women of reproductive age worldwide. It is characterized by a combination of clinical signs such as hirsutism, acne, and alopecia, biochemical markers including elevated serum androgens, and polycystic ovarian morphology on ultrasound.
Спросить CiteX об этой работе

Смежные источники